Motif Bio (MTFB) Savannah Petroleum (SAVP) Emmerson (EML) and Chris Bailey on (KGF) (RNK) (WG.)

Aug 16, 2018, 12:18 PM

On the Vox Markets Podcast Today - 16th August 2018

Graham Lumsden, CEO of Motif Bio (MTFB) explains the significance of FDA Acceptance of New Drug Application with Priority Review for their lead product, Iclaprim.

(Interview starts at 2 minute 3 seconds)

Andrew Knott, CEO of Savannah Petroleum (SAVP) talks about their fourth consecutive oil discovery and progress at the company.

(Interview starts at 7 minutes 38 seconds)

Phil Cleggett, Head of Corporate Development for Emmerson (EML) talks about how their exploration target has demonstrated large-scale potash potential at their Khemisset Project.

(Interview starts at 16 minute 35 seconds)

Chris Bailey founder of Financial Orbit covers: Kingfisher Group #KGF Rank Group #RNK & John Wood #WG.

(Interview starts at 22 minute 32 seconds)

Plus the Top 5 Most Followed Companies & the Top 5 Most Liked RNS’s on Vox Markets in the last 24 hours.

Vox Markets is revolutionising the way companies engage with shareholders and the stock market at large. By aggregating IR and digital content onto one secure and compliant platform, Vox Markets has established itself as the go-to resource for the investment community.

#VoxMarkets #StockMarket #LivePrices #StockMarketNews #Money #Investing #Finance #Business #Podcast

https://www.voxmarkets.co.uk/